Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo

Journal of Pathology

Volumn 180, Issue 3, 1996, Pages 243-248

  Sheu, Lai Fa ^a   Chen, Ann ^a   Meng, Ching Liang ^a   Ho, Kuo Chieh ^b   Lee, Wei Hwa ^a   Leu, Fur Jiang ^c   Chao, Chung Faye ^d  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^c CARDINAL TIEN HOSPITAL   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Epstein Barr virus; Nasopharyngeal carcinoma

Indexed keywords

VIRUS ANTIGEN;

ANIMAL MODEL; ARTICLE; CELL CULTURE; EPSTEIN BARR VIRUS; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; DISEASE PROGRESSION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HERPESVIRUS 4, HUMAN; MICE; MICE, NUDE; MICE, SCID; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; PRECIPITIN TESTS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 10544223747     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199611)180:3<243::AID-PATH655>3.0.CO;2-7     Document Type: Article

References (25)

1. Hanto DW, Frizzera G, Gail-Pecxalska KJ, Simmons RL. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation 1985; 39: 461-472.
2. zur Hausen H, Schulte-Holthausen H, Klein G, et al Epstein-Barr virus DNA in biopsies of Burkitt's tumors and anaplasic carcinoma of the nasopharynx. Nature 1970; 228: 1056-1058.
3. Saemundsen AK, Albeck H, Hansen JPH. Epstein-Barr virus in nasopharyngeal and salivary gland carcinoma of greenland Eskimos. Br J Cancer 1982; 46: 721-728.
4. Leyvraz S, Henle W, Chahinian AP, Perlman C, Klein G, Gordon RE. Association of Epstein-Barr virus with thymic carcinoma, N Engl J Med 1985; 312: 1296-1299.
5. Burke AP, Yen TSB, Shekitka KM, Sobin LH. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol 1990; 3: 377-380.
6. Shibata D, Tokunaga M, Uemura Y, Sato E, Tanaka S, Weiss LM. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Am J Pathol 1991; 139: 469-474.
7. Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976; 17: 1-7.
8. Naegele RF, Champion J, Murphy S, Henle G, Henle W. Nasopharyngeal carcinoma in American children. Epstein-Barr virus-specific antibody titer and prognosis. Int J Cancer 1982; 29: 209-212.
9. Ringborg U, Henle W, Henle G, et al. Epstein-Barr virus-specific serodiagnostic tests in carcinoma of the head and neck. Cancer 1983; 52: 1237-1243.
10. Young LS, Clark D, Sixbey JW, Rickinson AB. Epstein-Barr virus receptors on human pharyngeal epithelium. Lancet 1986; 1: 240-245.
11. Sixbey JW, Davis DS, Young LS, Hutt-Fletcher L, Tedder TF, Rickinson AB. Human epithelial cell expression of an Epstein-Barr virus receptor. J Gen Virol 1987; 68: 805-811.
12. Nancy RT, Felying K, Pearson G, et al. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 1987; 39: 25-29.
13. Fahraeus R, Fu HL, Ernberg I, et al. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988; 42: 329-338.
14. Young LS, Dawson CW, Clark D, et al. Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol 1988; 69: 1051-1065.
15. Jones CH, Hayward SD, Rawlins DR. Interaction of the lymphocyte-derived Epstein-Barr nuclear antigen EBNA-I with its DNA-binding sites. J Virol 1989; 63: 101-110.
16. Ohno S, Luka J, Lindahl T, Klein G. Identification of a purified complement-fixing antigen as the Epstein-Barr virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes. Proc Natl Acad Sci USA 1977; 74: 1605-1609.
17. Wilson JB, Levine AJ. The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice. Curr Topics Microbiol Immunol 1992; 182: 375-384.
18. Glaser R, Zhang HY, Yao K, et al. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. Proc Natl Acad Sci USA 1989; 86: 9524-9528.
19. Yao K, Zhang HY, Zhu HC, et al. Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas Int J Cancer 1990; 45: 83-89.
20. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of nasopharynx. Proc Natl Acad Sci USA 1974; 71: 4737-4741.
21. Hearing JC, Lewis A, Levine AJ. Structure of the Epstein-Barr virus nuclear antigen as probed with monoclonal antibodies. Virology 1985; 142: 215-220.
22. Banks-Schlegel S, Green H. Involucrin synthesis and tissue assembly by keratinocytes in natural and cultured human epithelia. J Cell Biol 1981; 90: 732-737.
23. Hudson DL, Weiland KL, Dooley TP, et al. Characterization of eight monoclonal antibodies to involucrin. Hybridoma 1992; 11: 367-379.
24. Wexler H. Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst 1966; 36: 641-645.
25. Levitskaya J, Coram M, Levitsky V, et al. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995; 375: 685-688.